167 related articles for article (PubMed ID: 22761580)
1. Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genes.
Simeonova I; Lejour V; Bardot B; Bouarich-Bourimi R; Morin A; Fang M; Charbonnier L; Toledo F
PLoS Genet; 2012 Jun; 8(6):e1002731. PubMed ID: 22761580
[TBL] [Abstract][Full Text] [Related]
2. Of mice and men: fuzzy tandem repeats and divergent p53 transcriptional repertoires.
Morin A; Bardot B; Simeonova I; Lejour V; Bouarich-Bourimi R; Toledo F
Transcription; 2013; 4(2):67-71. PubMed ID: 23412358
[TBL] [Abstract][Full Text] [Related]
3. RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation.
Schade AE; Fischer M; DeCaprio JA
Nucleic Acids Res; 2019 Dec; 47(21):11197-11208. PubMed ID: 31667499
[TBL] [Abstract][Full Text] [Related]
4. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins.
Böhlig L; Friedrich M; Engeland K
Nucleic Acids Res; 2011 Jan; 39(2):440-53. PubMed ID: 20833636
[TBL] [Abstract][Full Text] [Related]
5. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
Duan L; Perez RE; Calhoun S; Maki CG
Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
[TBL] [Abstract][Full Text] [Related]
6. Borealin is repressed in response to p53/Rb signaling.
Date DA; Jacob CJ; Bekier ME; Stiff AC; Jackson MW; Taylor WR
Cell Biol Int; 2007 Dec; 31(12):1470-81. PubMed ID: 17716930
[TBL] [Abstract][Full Text] [Related]
7. Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.
Litovchick L; Sadasivam S; Florens L; Zhu X; Swanson SK; Velmurugan S; Chen R; Washburn MP; Liu XS; DeCaprio JA
Mol Cell; 2007 May; 26(4):539-51. PubMed ID: 17531812
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.
Vilas JM; Ferreirós A; Carneiro C; Morey L; Da Silva-Álvarez S; Fernandes T; Abad M; Di Croce L; García-Caballero T; Serrano M; Rivas C; Vidal A; Collado M
Oncotarget; 2015 Feb; 6(5):2992-3002. PubMed ID: 25576924
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of retinoblastoma in Rb
Kooi IE; van Mil SE; MacPherson D; Mol BM; Moll AC; Meijers-Heijboer H; Kaspers GJ; Cloos J; Te Riele H; Dorsman JC
Genes Chromosomes Cancer; 2017 Mar; 56(3):231-242. PubMed ID: 27750399
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between p53 and p130(Rb2) in induction of cellular senescence.
Kapić A; Helmbold H; Reimer R; Klotzsche O; Deppert W; Bohn W
Cell Death Differ; 2006 Feb; 13(2):324-34. PubMed ID: 16123778
[TBL] [Abstract][Full Text] [Related]
11. Impact of Alu repeats on the evolution of human p53 binding sites.
Cui F; Sirotin MV; Zhurkin VB
Biol Direct; 2011 Jan; 6():2. PubMed ID: 21208455
[TBL] [Abstract][Full Text] [Related]
12. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.
Priya K; Jada SR; Quah BL; Quah TC; Lai PS
Cancer Biol Ther; 2009 Apr; 8(8):714-7. PubMed ID: 19252413
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 promotes cell cycle progression by down-regulating E2F transcription factor 4 and retinoblastoma family protein p130.
Park AM; Tsunoda I; Yoshie O
J Biol Chem; 2018 Oct; 293(41):15815-15826. PubMed ID: 30166342
[TBL] [Abstract][Full Text] [Related]
14. Inorganic arsenic exposure induces E2F-dependent G0/G1 arrest via an increase in retinoblastoma family protein p130 in B-cell lymphoma A20 cells.
Okamura K; Miki D; Nohara K
Genes Cells; 2013 Oct; 18(10):839-49. PubMed ID: 23890198
[TBL] [Abstract][Full Text] [Related]
15. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.
Uxa S; Bernhart SH; Mages CFS; Fischer M; Kohler R; Hoffmann S; Stadler PF; Engeland K; Müller GA
Nucleic Acids Res; 2019 Sep; 47(17):9087-9103. PubMed ID: 31400114
[TBL] [Abstract][Full Text] [Related]
16. Indirect p53-dependent transcriptional repression of Survivin, CDC25C, and PLK1 genes requires the cyclin-dependent kinase inhibitor p21/CDKN1A and CDE/CHR promoter sites binding the DREAM complex.
Fischer M; Quaas M; Nickel A; Engeland K
Oncotarget; 2015 Dec; 6(39):41402-17. PubMed ID: 26595675
[TBL] [Abstract][Full Text] [Related]
17. The role of the retinoblastoma/E2F1 tumor suppressor pathway in the lesion recognition step of nucleotide excision repair.
Lin PS; McPherson LA; Chen AY; Sage J; Ford JM
DNA Repair (Amst); 2009 Jul; 8(7):795-802. PubMed ID: 19376752
[TBL] [Abstract][Full Text] [Related]
18. From G0 to S phase: a view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway.
Sun A; Bagella L; Tutton S; Romano G; Giordano A
J Cell Biochem; 2007 Dec; 102(6):1400-4. PubMed ID: 17979151
[TBL] [Abstract][Full Text] [Related]
19. Orbital nodular fasciitis in child with biallelic germline RBL2 variant.
Rips J; Abu-Libdeh B; Koplewitz BZ; Kehat-Ophir S; Frenkel S; Elpeleg O; Harel T
Eur J Med Genet; 2022 Jun; 65(6):104513. PubMed ID: 35487417
[TBL] [Abstract][Full Text] [Related]
20. A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs.
Stik G; Laurent S; Coupeau D; Coutaud B; Dambrine G; Rasschaert D; Muylkens B
RNA; 2010 Nov; 16(11):2263-76. PubMed ID: 20881002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
